ג'מסיטאבין אקטביס 1000 מ"ג/בקבוקון

Χώρα: Ισραήλ

Γλώσσα: Εβραϊκά

Πηγή: Ministry of Health

Δραστική ουσία:

GEMCITABINE 1000 MG/VIAL

Διαθέσιμο από:

DEVRIES & CO. LTD

Φαρμακολογική κατηγορία (ATC):

L01BC05

Φαρμακοτεχνική μορφή:

POWDER FOR SOLUTION FOR INFUSION

Οδός χορήγησης:

I.V

Κατασκευάζεται από:

ACTAVIS GROUP PTC ehf, ICELAND

Θεραπευτική ομάδα:

GEMCITABINE

Θεραπευτικές ενδείξεις:

Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer in combination with cisplatin. Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas.Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). Gemcitabine monotherapy can be considered in elderly patients or those with performance status 2. Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first-line therapy. Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherap

Ημερομηνία της άδειας:

2013-06-01